JMP Securities Starts Terns Pharmaceuticals (TERN) at Market Outperform

February 14, 2023 2:21 AM EST Send to a Friend
JMP Securities analyst Silvan Tuerkcan initiates coverage on Terns Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login